对dieckol抗癌性质的分子洞察力:一个全面的综述
Anandakumar Pandi1, Nabendu Sen2, Vanitha Manickam Kalappan3
1Department of Biochemistry, All India Institute of Medical Sciences, Deoghar, Jharkhand, India. bioanand77@gmail.com.
Naunyn-Schmiedeberg's archives of pharmacology
|October 22, 2025
概括
迪科尔 (Dieckol) 是棕藻中的一种化合物,通过触发癌细胞死亡和抑制瘤扩散,显示出显著的抗癌潜力. 这种天然化合物为癌症预防和治疗提供了前途.
科学领域:
- 海洋天然产品 海洋天然产品
- 罗氨酸氨酸 是一种氨酸.
- 癌症生物学 癌症生物学
背景情况:
- 癌症是全球主要的健康问题.
- 自然化合物正在探索用于癌症治疗.
- 来自Ecklonia cava的Dieckol表现出抗癌性质.
研究的目的:
- 为了审查迪科尔的抗癌机制.
- 为了分析它的分子目标.
- 评估其治疗前景.
主要方法:
- 关于迪科尔抗癌作用的文献综述.
- 分析其对细胞过程的影响.
- 检查其对信号通路的影响.
主要成果:
- 迪科尔具有抗氧化和抗炎作用.
- 它诱导癌细胞的亡和自.
- 它抑制了瘤的入侵,转移和血管生成.
- 它破坏了关键的瘤信号通路 (PI3K/Akt/mTOR,NF-κB,JAK/STAT3,FAK).
结论:
- 迪科尔证明了多方面的抗癌机制.
- 它显示了癌症预防和治疗的潜力.
- 需要进一步的研究来探索其临床应用.
更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


